Delivery Order SPE2DE24D0013-SPE2D625F2QGG
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 17, 2025, and carries no set-aside designation. The contract nomenclature indicates the order involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial...
- The U.S. Defense Department's Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance completion targeted for September 16, 2025. The contract contains no set-aside designation and represents a...
- The Defense Department's Medical Supply Chain division awarded a $13,096.80 firm fixed-price delivery order to Cepheid Inc. on May 27, 2025, for molecular diagnostic testing solutions. This delivery order, designated XPCOV2/FLU/RSV-10 and scheduled for completion by June 10, 2025, is expected to be performed at Cepheid's Sunnyvale, California headquarters. The contract carries no set-aside designation and represents a continuation of Cepheid's ongoing supply of diagnostic capabilities to the...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,480 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, on September 5, 2025, with completion targeted for September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside designation and represents a continuation of Cepheid's...
- The U.S. Defense Department's Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $20,400 on August 11, 2025, with an ultimate completion date of August 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious diseases commonly detected through Cepheid's GeneXpert molecular...
- The Defense Department's Medical Supply Chain awarded a $25,920 firm fixed-price delivery order to Cepheid Inc. on September 9, 2025, with an ultimate completion date of September 16, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions from the Sunnyvale, California-based manufacturer, likely supporting testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection across federal healthcare systems. This award carries...
- The Defense Department's Medical Supply Chain awarded a $17,280 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 3, 2025, with completion targeted for September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and procures diagnostic testing solutions, likely reagents and assays for COVID-19, influenza, and respiratory syncytial virus detection based on the contract...
- The Department of Defense's Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 10, 2025, with completion scheduled for September 17, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—critical infectious disease detection capabilities aligned with DoD's health...
- The U.S. Defense Department's Medical Supply Chain awarded a $204,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 22, 2025, and carries no set-aside designation. This award represents a continuation of the department's partnership with Cepheid to procure diagnostic testing solutions, specifically for...
- The U.S. Department of Defense's Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on July 14, 2025, with an ultimate completion date of July 21, 2025, is designated as XPCOV2/FLU/RSV-10, indicating it relates to diagnostic testing for COVID-19, influenza, and respiratory syncytial virus. The contract carries no set-aside designation and represents a...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2QGGDelivery Order
The U.S. Department of Defense's Medical Supply Chain awarded a $13.6K firm fixed-price delivery order to Cepheid Inc. on September 4, 2025, with completion scheduled for September 11, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions from the Sunnyvale, California-based manufacturer, likely supporting COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities across military healthcare systems. The award carries no set-aside designation and represents a continuation of Cepheid's established role as a primary supplier of GeneXpert diagnostic systems and associated reagents to federal healthcare entities. This delivery order appears to be issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts, which provide the company with flexible procurement mechanisms for ongoing diagnostic supply needs. Cepheid's federal contract portfolio demonstrates consistent demand for its molecular diagnostic platforms across the Department of Veterans Affairs, Defense Logistics Agency, and Defense Health Agency. The company's expertise in rapid infectious disease detection and its established relationships with federal healthcare networks position it as a critical supplier for maintaining diagnostic readiness within the military medical supply chain, particularly for communicable disease surveillance and point-of-care testing capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 9/4/25 |